Bodily expression of felt emotion has been documented in the literature. However, it is often associated with high motor variability between individuals. This study aimed to identify individual motor signature (IMS) of emotions. IMS is a new method of motion analysis and visualization able to capture the subtle differences in the way each of us moves, seen as a kinematic fingerprint. We hypothesized that the individual motor signature would be different depending on the induced emotional state and that an emotional motor signature of joy and sadness common to all participants would emerge. For that purpose, we elicited these emotions (joy, sadness, and a neutral control emotion) in 26 individuals using an autobiographical memory paradigm, before they performed a motor improvization task (e.g., the mirror game). We extracted the individual motor signature under each emotional condition. Participants completed a self-report emotion before and after each trial. Comparing the similarity indexes of intra- and inter-emotional condition signatures, we confirmed our hypothesis and showed the existence of a specific motor signature for joy and sadness, allowing us to introduce the notion of emotional individual motor signature (EIMS). Our study indicates that EIMS can reinforce emotion discrimination and constitutes the first step in modeling emotional behavior during individual task performances or social interactions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237757 | PMC |
http://dx.doi.org/10.3389/fpsyg.2021.647704 | DOI Listing |
Elife
January 2025
National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.
Co-active or temporally ordered neural ensembles are a signature of salient sensory, motor, and cognitive events. Local convergence of such patterned activity as synaptic clusters on dendrites could help single neurons harness the potential of dendritic nonlinearities to decode neural activity patterns. We combined theory and simulations to assess the likelihood of whether projections from neural ensembles could converge onto synaptic clusters even in networks with random connectivity.
View Article and Find Full Text PDFExp Biol Med (Maywood)
January 2025
Institute of Clinical Medicine, University Tartu, Tartu, Estonia.
Blood-based biomarkers for motor neuron disease are needed for better diagnosis, progression prediction, and clinical trial monitoring. We used whole blood-derived total RNA and performed whole transcriptome analysis to compare the gene expression profiles in (motor neurone disease) MND patients to the control subjects. We compared 42 MND patients to 42 aged and sex-matched healthy controls and described the whole transcriptome profile characteristic for MND.
View Article and Find Full Text PDFInt Immunopharmacol
January 2025
Department of Orthopedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000 China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou 325000 China; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325000 China. Electronic address:
Spinal cord injury (SCI) is a potentially fatal condition that often results in loss of motor and sensory functions, thereby significantly burdening global health initiatives. Urolithin A (UA), an intestinal microbial metabolite of ellagic acid, is known for its potent anti-inflammatory properties in chronic inflammation contexts. UA treatment in humans induces a molecular signature of improved mitochondrial and cellular health.
View Article and Find Full Text PDFHum Mol Genet
January 2025
Centre for Discovery Brain Sciences, Hugh Robson Building, George Square, University of Edinburgh, Edinburgh EH8 9XD, United Kingdom.
Spinal Muscular Atrophy is an autosomal dominant disease caused by mutations and deletions within the SMN1 gene, with predominantly childhood onset. Although primarily a motor neuron disease, defects in non-neuronal tissues are described in both patients and mouse models. Here, we have undertaken a detailed study of the heart in the Smn2B/- mouse models of SMA, and reveal a thinning of the ventriclar walls as previously described in more severe mouse models of SMA.
View Article and Find Full Text PDFBMC Med Genomics
January 2025
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
Amyotrophic lateral sclerosis (ALS) lacks a specific biomarker, but is defined by relatively selective toxicity to motor neurons (MN). As others have highlighted, this offers an opportunity to develop a sensitive and specific biomarker based on detection of DNA released from dying MN within accessible biofluids. Here we have performed whole genome bisulfite sequencing (WGBS) of iPSC-derived MN from neurologically normal individuals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!